Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Radiotherapy, Image-Guided × Clear all

NCT04003246 2025-03-21

Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer

Phase 2 Completed

10 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms